Citrate as a Regional Anticoagulant in Sustained Low Efficiency Hemodialysis and Continuous Veno - Venus Hemofiltration
Bae, Alexander J.
MetadataShow full item record
Over the course of the 2010 calendar year, various patients were selected at random from a pool of patients that displayed acute renal failure. These patients displayed chronic kidney disease (CKD) and were treated with 24 hour sustained low efficiency dialysis (SLED) with citrate as an anticoagulant. Through CarePlus, the Henry Ford Hospital patient database, the vital statistics of each patient were collected for all 24 hour SLED treatments. Labs from each treatment were organized into spreadsheet data sorted by date and time. The categories included serum albumin (ALB), blood urea nitrogen (BUN), calcium (CA), carbon dioxide (C02), ionized calcium (ICA), ionized calcium whole blood (ICAW), lactate whole blood (LACW), sodium (NA), phosphorous (PHOS), total bilirubin (TBIL), chloride (CL), creatinine (CRET), hemoglobin (HGB), prothrombin time (INR), potassium (K), and magnesium (MG). For each category, the average, standard deviation, and total count were all calculated. These averages were combined to compare the effectiveness of SLED with citrate at the molecular level. Through Greenfield Health Systems, the treatment data sheets were all collected. These data sheets contained the data given by the dialysis machines during treatments. These data points were also sorted by date and time. The categories include hemoglobin (hb), oxygen saturation, hourly fluid removal, citrate infusion, calcium and magnesium infusion, hourly net fluid removal, solute clearance, ionized calcium. The data was then graphed to show various corporeal values during treatment.